Page last updated: 2024-08-23

bm 13505 and Coronary Artery Disease

bm 13505 has been researched along with Coronary Artery Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hartig, F; Metz, J; Pill, J; Stegmeier, K	1

Other Studies

1 other study(ies) available for bm 13505 and Coronary Artery Disease

Article	Year
Effects of daltroban, a thromboxane (TX) A2 receptor antagonist, on lipid metabolism and atherosclerosis. Agents and actions. Supplements, 1992, Volume: 37 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cells, Cultured; Cholesterol Esters; Coronary Artery Disease; Diet, Atherogenic; In Vitro Techniques; Lipid Metabolism; Male; Microsomes; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Rabbits; Rats; Sterol O-Acyltransferase; Sulfonamides; Thromboxanes; Vasoconstrictor Agents	1992

Article

Year

Effects of daltroban, a thromboxane (TX) A2 receptor antagonist, on lipid metabolism and atherosclerosis.

Agents and actions. Supplements, 1992, Volume: 37

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cells, Cultured; Cholesterol Esters; Coronary Artery Disease; Diet, Atherogenic; In Vitro Techniques; Lipid Metabolism; Male; Microsomes; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Rabbits; Rats; Sterol O-Acyltransferase; Sulfonamides; Thromboxanes; Vasoconstrictor Agents

1992